AbbVie Sues Alvotech Again Alleging At-Risk Adalimumab Launch
Second Lawsuit For Infringement Under BPCIA
In the latest twist in the tussle between Alvotech and AbbVie over Humira intellectual property, the originator has sued the Icelandic firm for a second time in a court in Illinois, in an attempt to enforce almost 60 patents that it says Alvotech has previously declined to litigate.
